Patients with HR+/HER2− metastatic breast cancer without previous systemic therapy were randomly assigned to receive either ...

At Allegheny General Hospital, a new pilot program is focusing on patients diagnosed with metastatic breast cancer. It's a ...

An MP has said she has been diagnosed with breast cancer for a second time. Labour MP for West Lancashire Ashley Dalton said ...

Incredible” results from the PATINA trial suggested a new standard of care for HER2, ER-positive metastatic breast cancer.

It’s been months in the making, but now the new resource is available for those battling the treatable, but incurable form of ...

Women diagnosed with advanced breast cancer appeared more likely than those with earlier-stage breast cancer to have ...

Viracta Therapeutics announced the closure of a phase II trial of its combination therapy of the histone deacetylase ...

Tumor cells circulating in the blood are the 'germ cells' of breast cancer metastases. They are very rare and could not be propagated in the culture dish until now, which made research into therapy ...

Allegheny Health Network's Cancer Institute announced Wednesday the launch of a pilot program addressing the mental health ...

Mersana on Friday said the new designation covers the drug, XMT-1660, for the treatment of advanced or metastatic breast cancer in patients with human epidermal growth factor receptor 2 low or ...

The addition of camrelizumab to platinum-containing intensive neoadjuvant chemotherapy improved pathologic complete response ...

Phase 3 data support pyrotinib plus trastuzumab and docetaxel “as a well-established and effective treatment strategy,” according to Binghe Xu, MD.